Analyzing Autonomix Medical (AMIX) & Its Rivals

Autonomix Medical (NASDAQ:AMIX) is one of 236 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its competitors? We will compare Autonomix Medical to similar businesses based on the strength of its earnings, risk, analyst recommendations, institutional ownership, valuation, profitability and dividends.

Institutional and Insider Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 47.9% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by insiders. Comparatively, 15.5% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Autonomix Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-574.62%	-156.70%	-27.31%

Valuation & Earnings

This table compares Autonomix Medical and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.39
Autonomix Medical Competitors	$1.03 billion	$10.63 million	-6.55

Autonomix Medical’s competitors have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Autonomix Medical and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1910	4904	9145	268	2.48

Autonomix Medical presently has a consensus target price of $28.00, suggesting a potential upside of 342.34%. As a group, “Surgical & medical instruments” companies have a potential upside of 15.53%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, equities analysts clearly believe Autonomix Medical is more favorable than its competitors.

Autonomix Medical Company Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.